Tag - vaccine platforms

Latest Science

Feature: The 2026 vaccine licenses: influenza drives a new platform era

The most revealing feature of vaccine licensure in 2026 is not a newly targeted pathogen. It is the concentration of innovation around familiar respiratory threats: seasonal influenza and COVID-19. Four notable...

23 September, 2026

11 min read

Latest Science

ViVa 37 Feature: Influenza vaccines for the 2026–2027 respiratory season

For decades, seasonal influenza vaccines were produced primarily in embryonated eggs. Live attenuated influenza vaccine (LAIV), administered intranasally, became available in 2003. Over the past decade, additional...

16 September, 2026

11 min read